D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 22,171 577 World Ranking 11684 National Ranking 1065

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Gene

His primary areas of investigation include Endocrinology, Internal medicine, Insulin, Diabetes mellitus and Type 2 diabetes. As part of his studies on Endocrinology, Peter R. Flatt frequently links adjacent subjects like Dipeptidyl peptidase. Glucose homeostasis, Incretin, Receptor, Islet and Glucagon are among the areas of Internal medicine where the researcher is concentrating his efforts.

His work deals with themes such as Biological activity and Carbohydrate metabolism, Biochemistry, Peptide, which intersect with Insulin. In his research on the topic of Diabetes mellitus, Botany, Sativum and Coriandrum is strongly related with Traditional medicine. His Type 2 diabetes research includes elements of Metformin and Enzyme.

His most cited work include:

  • Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice (366 citations)
  • Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. (358 citations)
  • Characterization of a Novel Glucose-Responsive Insulin-Secreting Cell Line, BRIN-BD11, Produced by Electrofusion (324 citations)

What are the main themes of his work throughout his whole career to date?

Peter R. Flatt mainly investigates Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Biochemistry. His Internal medicine research integrates issues from Glucagon-like peptide-1, Peptide and Streptozotocin. Endocrinology is a component of his Glucose homeostasis, Type 2 diabetes, Glucagon, Beta cell and Insulin resistance studies.

His Insulin study integrates concerns from other disciplines, such as Biological activity and Pharmacology. His biological study spans a wide range of topics, including Hormone and Obesity. A large part of his Biochemistry studies is devoted to Amino acid.

He most often published in these fields:

  • Internal medicine (76.37%)
  • Endocrinology (75.89%)
  • Insulin (52.74%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (76.37%)
  • Endocrinology (75.89%)
  • Insulin (52.74%)

In recent papers he was focusing on the following fields of study:

Peter R. Flatt mainly focuses on Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Islet. His Internal medicine research incorporates themes from Liraglutide and Peptide. His study in Endocrinology focuses on Glucagon, Beta cell, Type 2 diabetes, Streptozotocin and Insulin resistance.

His study in Insulin is interdisciplinary in nature, drawing from both Hormone, Glucagon-like peptide-1 and Pharmacology. His Diabetes mellitus study combines topics in areas such as Obesity and Neuroprotection. The Islet study combines topics in areas such as Neuropeptide and Peptide YY.

Between 2014 and 2021, his most popular works were:

  • Glucagon-like peptide 1 (GLP-1) (164 citations)
  • Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline (85 citations)
  • A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice. (53 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Internal medicine
  • Gene

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Beta cell. Internal medicine is closely attributed to Streptozotocin in his work. His Endocrinology study frequently links to adjacent areas such as Xenin.

His research integrates issues of In vitro, Glucagon-like peptide-1, Type 2 diabetes, Fatty acid and Neurogenesis in his study of Insulin. The concepts of his Diabetes mellitus study are interwoven with issues in Hormone, Receptor and Neuroprotection, Pharmacology. His Beta cell research is multidisciplinary, incorporating elements of Arginine vasopressin receptor 2, Posterior pituitary, Genetic enhancement, Cell therapy and Vasopressin receptor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice

S. K. Swanston-Flatt;C. Day;C. J. Bailey;P. R. Flatt.
Diabetologia (1990)

614 Citations

Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice.

P. R. Flatt;C. J. Bailey.
Diabetologia (1981)

445 Citations

Insulin-releasing and insulin-like activity of the traditional anti-diabetic plant Coriandrum sativum (coriander).

Alison M. Gray;Peter R. Flatt.
British Journal of Nutrition (1999)

424 Citations

Characterization of a Novel Glucose-Responsive Insulin-Secreting Cell Line, BRIN-BD11, Produced by Electrofusion

Neville H McClenaghan;Christopher R Barnett;Eric Ah-Sing;Yasser H A Abdel-Wahab.
Diabetes (1996)

379 Citations

The effects of traditional antidiabetic plants on in vitro glucose diffusion

Alison Gallagher;Peter Flatt;G Duffy;Yasser Abdel-Wahab.
Nutrition Research (2003)

304 Citations

Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action

J. M. A. Hannan;L. Ali;B. Rokeya;J. Khaleque.
British Journal of Nutrition (2007)

272 Citations

Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice.

S K Swanston-Flatt;C Day;P R Flatt;B J Gould.
Diabetes research (Scotland) (1989)

268 Citations

Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes

Brian D Green;Peter R Flatt;Clifford J Bailey.
Diabetes and Vascular Disease Research (2006)

266 Citations

Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes

John Lindsay;Nicola Duffy;Aine Mckillop;Joy Ardill.
Diabetic Medicine (2005)

239 Citations

The Traditional Plant Treatment, Sambucus nigra (elder), Exhibits Insulin-Like and Insulin-Releasing Actions In Vitro

Alison M. Gray;Yasser H. A. Abdel-Wahab;Peter R. Flatt.
Journal of Nutrition (2000)

237 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter R. Flatt

Jens J. Holst

Jens J. Holst

University of Copenhagen

Publications: 83

Philip Newsholme

Philip Newsholme

Curtin University

Publications: 66

J. Michael Conlon

J. Michael Conlon

University of Ulster

Publications: 52

Clifford J. Bailey

Clifford J. Bailey

Aston University

Publications: 45

Daniel J. Drucker

Daniel J. Drucker

Lunenfeld-Tanenbaum Research Institute

Publications: 45

Willy Malaisse

Willy Malaisse

Université Libre de Bruxelles

Publications: 31

Filip K. Knop

Filip K. Knop

University of Copenhagen

Publications: 29

Per-Olof Berggren

Per-Olof Berggren

Karolinska Institute

Publications: 29

Matthias H. Tschöp

Matthias H. Tschöp

Technical University of Munich

Publications: 27

Fiona M. Gribble

Fiona M. Gribble

University of Cambridge

Publications: 26

Bo Ahrén

Bo Ahrén

Lund University

Publications: 25

Frank Reimann

Frank Reimann

University of Cambridge

Publications: 24

Carolyn F. Deacon

Carolyn F. Deacon

University of Copenhagen

Publications: 24

Rui Curi

Rui Curi

Universidade Cruzeiro do Sul

Publications: 23

Stephen R. Bloom

Stephen R. Bloom

Imperial College London

Publications: 23

Mette M. Rosenkilde

Mette M. Rosenkilde

University of Copenhagen

Publications: 22

Something went wrong. Please try again later.